Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production

Hypertension Research

Volumn 31, Issue 2, 2008, Pages 305-313

  Fujimoto, Sohachi ^a   Satoh, Minoru ^a   Horike, Hideyuki ^a   Hatta, Hidekazu ^a   Haruna, Yoshisuke ^a   Kobayashi, Shinya ^a   Namikoshi, Tamehachi ^a   Arakawa, Sayaka ^a   Tomita, Naruya ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; NAD(P)H oxidase; Nephrectomy; Olmesartan

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN; DIPHENYLIODONIUM SALT; HYDRALAZINE; MESSENGER RNA; OLMESARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME SUBUNIT; GLOMERULOSCLEROSIS; KIDNEY FAILURE; KIDNEY INJURY; MALE; NEPHRECTOMY; NITROSATIVE STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; IMIDAZOLES; KIDNEY GLOMERULUS; MALE; NADPH OXIDASE; NEPHRECTOMY; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RNA, MESSENGER; SUPEROXIDES; TETRAZOLES;

EID: 41549162787     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.305     Document Type: Article

References (42)

1. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-474.
2. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992; 304: 339-343.
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, The Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
4. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
5. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993; 265: F477-F486.
6. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factoy-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437.
7. Anderson PW, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993; 21: 29-35.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
9. Cifuentes ME, Rey FE, Carretero OA, Pagano PJ: Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 2000; 279: H2234-H2240.
10. Yoshimoto T, Gochou N, Fukai N, Sugiyama T, Shichiri M, Hirata Y: Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 2005; 28: 165-172.
11. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK: Requirement of Racl in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006; 103: 7432-7437.
12. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998; 54: 775-784.
13. Ushio-Fukai M, Alexander RW, Akers M, et al: Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999; 274: 22699-22704.
14. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW: Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21: 489-495.
15. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB: Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-651.
16. Van den Branden C, Ceyssens B, Pauwels M, et al: Effect of mycophenolate moletil on glomerulosclerosis and renal oxidative stress in rats. Nephron Exp Nephrol 2003; 95: e93-e99.
17. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, Pavenstadt H: NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 1998; 53: 654-663.
18. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003; 14: S250-S253.
19. Namikoshi T, Tomita N, Fujimoto S, et al: Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats. Hypertens Res 2007; 30: 175-184.
20. Satoh M, Fujimoto S, Haruna Y, et al: NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F1144-F1152.
21. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
22. Ishii N, Patel KP, Lane PH, et al: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 2001; 12: 1630-1639.
23. Hahn S, Kuemmerle NB, Chan W, et al: Glomerulosclerosis in the remnant kidney rat is modulated by dietary alphatocopherol. J Am Soc Nephrol 1998; 9: 2089-2095.
24. Shimizu MH, Coimbra TM, de Araujo M, Menezes LF, Seguro AC: N-Acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; 68: 2208-2217.
25. Ueno T, Kaname S, Takaichi K, et al: LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res 2003; 26: 117-122.
26. Noda M, Matsuo T, Fukuda R, et al: Effect of candesartan cilexetil (TCV- 116) in rats with chronic renal failure, Kidney Int 1999; 56: 898-909.
27. Yao L, Kobori H, Rahman M, et al: Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004; 27: 493-500.
28. Geiszt M, Kopp JB, Varnai P, Leto TL: Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 2000; 97: 8010-8014.
29. Li JM, Shah AM: Mechanism of endothelial cell NADPH oxidase activation by angiotensin 11. Role of the p47phox subunit. J Biol Chem 2003; 278: 12094-12100.
30. Bidani AK, Griffin KA: Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 2004; 44: 595-601.
31. Takenaka T, Suzuki H, Okada H, et al: Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int 2002; 62: 558-565.
32. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993; 91: 2012-2019.
33. Goncalves AR, Fujihara CK, Mattar AL, et al: Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol Renal Physiol 2004; 286: F945-F954.
34. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S: Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94: 2407-2413.
35. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 1995; 48: 20-32.
36. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A: Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-111.
37. Zhang W, Khanna P, Chan LL, Campbell G, Ansari NH: Diabetes-induced apoptosis in rat kidney. Biochem Mol Med 1997; 61: 58-62.
38. Ying WZ, Wang PX, Sanders PW: Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int 2000; 58: 2007-2017.
39. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 1996; 7: 2357-2363.
40. Marshall CB, Pippin JW, Krofft RD, Shankland SJ: Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int 2006; 70: 1962-1973.
41. Macconi D, Bonomelli M, Benigni A, et al: Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 2006; 168: 42-54.
42. Kashihara N, Sugiyama H, Makino H: Mechanisms for induction of apoptosis and glomerular disease. Nephrol Dial Transplant 1999; 14 (Suppl 1): 52-54.